Fisher & Paykel reports cyber breach. Fisher & Paykel Healthcare stock is worth NZD 28.7 billion
Published on 10/25/2026 at 01:29 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSCyber response and reporting dates
- The October 22, 2026 incident involved access to two employee email accounts and company files.
- Fiscal year 2026 revenue reached NZD 2,308.4 million and net income NZD 468.5 million.
- Fisher & Paykel Healthcare stock closed at NZD 48.87 on October 23, 2026 on the NZX.
Fisher & Paykel Healthcare (NZFAPE0001S2) said two employee email accounts and a subset of company files were accessed in an incident disclosed on October 22, 2026. According to Fisher & Paykel Healthcare, products, manufacturing operations and the supply chain continued uninterrupted.
Fiscal 2026 gives a financial base
The cyber disclosure comes against a substantially larger earnings base. Reuters lists fiscal year 2026 revenue of NZD 2,308.4 million and net income of NZD 468.5 million. Simply Wall St reports that revenue increased 14 percent and net profit rose 24 percent in that fiscal year.
That comparison matters because the breach statement was operational rather than financial. The company said it had contained the incident, found no evidence of ransomware or malware, and expected no material impact on financials or operations. Some accessed files contained personally identifiable information, and notification work was underway.
Three dated developments shape the picture
On October 1, 2026, Fisher & Paykel Healthcare issued 13,631 ordinary shares to North American employees under its employee share purchase plan, according to FinancialFilings. On October 5, 2026, the company agreed to sell 13 hectares of its Drury site to Health New Zealand for NZD 45.3 million, as stated in its company release. On October 22, 2026, it disclosed the cyber incident involving two employee email accounts and company files.
What does the breach change?
The immediate investor question is whether the event reaches production, patient systems or guidance. The company described continuity across products, manufacturing and supply, while its fiscal 2026 results provide NZD 468.5 million of net income against NZD 2,308.4 million of revenue. That combination makes the incident a governance and data-protection issue in the disclosed facts, rather than a reported interruption to the operating model.
Reporting dates set the next checkpoints
Simply Wall St lists November 26, 2026 as the date for first-half fiscal 2027 results. The official land-sale release places settlement between March and June 2027, subject to sale conditions, giving the property transaction a separate longer-dated checkpoint.
FPH stays near its yearly high
Fisher & Paykel Healthcare closed at NZD 48.87 on the NZX on October 23, 2026. The quoted 52-week range was NZD 32.16 to NZD 49.63, putting the closing level NZD 0.76 below the high. Its market capitalization was NZD 28.7 billion as of October 23, 2026.
Fisher & Paykel Healthcare at a glance
- Company: Fisher & Paykel Healthcare Corporation Limited
- ISIN: NZFAPE0001S2
- Ticker: FPH
- Primary exchange: NZX
- Last NZX close (as of October 23, 2026): NZD 48.87
- Market capitalization: NZD 28.7 billion (as of October 23, 2026)
- 52-week range: NZD 32.16-NZD 49.63
- Sector / Industry: Healthcare / Medical Equipment, Supplies and Distribution
Market context: Latest market reports.
